109 related articles for article (PubMed ID: 7735798)
1. Experience with the second generation UroLume prostatic stent.
Bajoria S; Agarwal SA; White R; Zafar F; Williams G
Br J Urol; 1995 Mar; 75(3):325-7. PubMed ID: 7735798
[TBL] [Abstract][Full Text] [Related]
2. The urolume, a permanently implanted prostatic stent for patients at high risk for surgery. Results from 5 collaborative centres.
Williams G; Coulange C; Milroy EJ; Sarramon JP; Rubben H
Br J Urol; 1993 Sep; 72(3):335-40. PubMed ID: 7693296
[TBL] [Abstract][Full Text] [Related]
3. The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia.
Masood S; Djaladat H; Kouriefs C; Keen M; Palmer JH
BJU Int; 2004 Dec; 94(9):1271-4. PubMed ID: 15610103
[TBL] [Abstract][Full Text] [Related]
4. The UroLume stent in the management of benign prostatic hyperplasia.
Milroy E; Chapple CR
J Urol; 1993 Nov; 150(5 Pt 2):1630-5. PubMed ID: 7692100
[TBL] [Abstract][Full Text] [Related]
5. Thermo-expandable prostatic stents for bladder outlet obstruction in the frail and elderly population: An underutilized procedure?
Sethi K; Bozin M; Jabane T; McMullin R; Cook D; Forsyth R; Dodds L; Putra LJ
Investig Clin Urol; 2017 Nov; 58(6):447-452. PubMed ID: 29124245
[TBL] [Abstract][Full Text] [Related]
6. Epithelializing stent for benign prostatic hyperplasia: a systematic review of the literature.
Armitage JN; Cathcart PJ; Rashidian A; De Nigris E; Emberton M; van der Meulen JH
J Urol; 2007 May; 177(5):1619-24. PubMed ID: 17437773
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable braided poly(lactic-co-glycolic acid) urethral stent combined with dutasteride in the treatment of acute urinary retention due to benign prostatic enlargement: a pilot study.
Kotsar A; Isotalo T; Juuti H; Mikkonen J; Leppiniemi J; Hänninen V; Kellomäki M; Talja M; Tammela TL
BJU Int; 2009 Mar; 103(5):626-9. PubMed ID: 18990149
[TBL] [Abstract][Full Text] [Related]
8. Prostatic UroLume Wallstent for urinary retention due to advanced prostate cancer: a 1-year followup study.
Guazzoni G; Montorsi F; Bergamaschi F; Consonni P; Rigatti P
J Urol; 1994 Nov; 152(5 Pt 1):1530-2. PubMed ID: 7933192
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical results and quality of life after insertion of a self-expanding flexible endourethral prosthesis.
Anjum MI; Chari R; Shetty A; Keen M; Palmer JH
Br J Urol; 1997 Dec; 80(6):885-8. PubMed ID: 9439402
[TBL] [Abstract][Full Text] [Related]
10. The use of a removable stent in patients with prostate cancer and obstruction.
Yachia D; Aridogan IA
J Urol; 1996 Jun; 155(6):1956-8. PubMed ID: 8618296
[TBL] [Abstract][Full Text] [Related]
11. A modified prostatic UroLume Wallstent for healthy patients with symptomatic benign prostatic hyperplasia: a European Multicenter Study.
Guazzoni G; Montorsi F; Coulange C; Milroy E; Pansadoro V; Rubben H; Sarramon JP; Williams G
Urology; 1994 Sep; 44(3):364-70. PubMed ID: 7521092
[TBL] [Abstract][Full Text] [Related]
12. The titanium intraprostatic stent: the United States experience.
Kaplan SA; Merrill DC; Mosely WG; Benson RC; Chiou RK; Fuselier HA; Parra RO
J Urol; 1993 Nov; 150(5 Pt 2):1624-9. PubMed ID: 7692099
[TBL] [Abstract][Full Text] [Related]
13. [Long-term results and indications of intraurethral stents in elderly patients with prostatic hypertrophy complaining of urinary retention].
Takeda M; Takahashi H; Tsutsui T; Go H; Hatano A; Sato S; Sasagawa T; Sakata Y; Hiraiwa M; Ando T
Hinyokika Kiyo; 1993 Nov; 39(11):1011-5. PubMed ID: 7505521
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of prostatic stent treatment for benign prostatic hyperplasia.
Chiou RK; Chen WS; Akbari A; Foley S; Lynch B; Taylor RJ
Urology; 1996 Oct; 48(4):589-93. PubMed ID: 8886065
[TBL] [Abstract][Full Text] [Related]
15. Prostate stent is an option for selected patients who are unsuitable for transurethral resection of the prostate.
Skydsgaard Schou-Jensen K; Dahl C; Azawi NH
Dan Med J; 2014 Oct; 61(10):A4937. PubMed ID: 25283624
[TBL] [Abstract][Full Text] [Related]
16. [Outcome analysis of the urethral stent (Memotherm®)].
Sakamoto H; Matsuda A; Arakaki R; Yamada H
Hinyokika Kiyo; 2012 Jan; 58(1):13-6. PubMed ID: 22343737
[TBL] [Abstract][Full Text] [Related]
17. Experience with the Memotherm permanently implanted prostatic stent.
Williams G; White R
Br J Urol; 1995 Sep; 76(3):337-40. PubMed ID: 7551842
[TBL] [Abstract][Full Text] [Related]
18. The North American experience with the UroLume endoprosthesis as a treatment for benign prostatic hyperplasia: long-term results. The North American UroLume Study Group.
Oesterling JE; Kaplan SA; Epstein HB; Defalco AJ; Reddy PK; Chancellor MB
Urology; 1994 Sep; 44(3):353-62. PubMed ID: 7521091
[TBL] [Abstract][Full Text] [Related]
19. Prostatic stents for the treatment of benign prostatic hyperplasia.
Vanderbrink BA; Rastinehad AR; Badlani GH
Curr Opin Urol; 2007 Jan; 17(1):1-6. PubMed ID: 17143103
[TBL] [Abstract][Full Text] [Related]
20. Prostatic spiral versus prostatic urolume wallstent for urinary retention due to benign prostatic hyperplasia. A long-term comparative study.
Guazzoni G; Montorsi F; Bergamaschi F; Consonni P; Bellinzoni P; Rigatti P
Eur Urol; 1993; 24(3):332-6. PubMed ID: 7505225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
